← Back to Search

Advanced Sound Processing for Hearing Loss

N/A
Recruiting
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Between the ages of 18 and 65
Have bilateral, symmetric sensorineural hearing loss that is less than 75 decibels (dB) Hearing Level (HL) at 1000 Hz and below.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 15 minutes
Awards & highlights

Study Summary

This trial looks at how changing how we process sound affects how we interpret speech.

Who is the study for?
This trial is for English-speaking adults aged 18-65 with bilateral, symmetric sensorineural hearing loss that's less than 75 dB at low frequencies. It excludes non-native English speakers, those with normal or mixed hearing loss, asymmetric hearing loss, and severe loss above 70 dB at higher frequencies.Check my eligibility
What is being tested?
The study tests the Tympan device to see how its nonlinear signal processing algorithms affect speech understanding in people with certain types of hearing loss.See study design
What are the potential side effects?
Since this trial involves a non-invasive device designed to improve speech perception, side effects are minimal but may include discomfort from wearing the device.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 65 years old.
Select...
My hearing loss in both ears is less than 75 dB at low tones.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~15 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 15 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Speech understanding
Secondary outcome measures
Preference

Trial Design

1Treatment groups
Experimental Treatment
Group I: Perceptual measuresExperimental Treatment1 Intervention
Perception will be measured for different algorithm settings and environmental variables (type of noise and signal-to-noise ratio)

Find a Location

Who is running the clinical trial?

Indiana UniversityLead Sponsor
980 Previous Clinical Trials
981,712 Total Patients Enrolled

Media Library

Perceptual measures Clinical Trial Eligibility Overview. Trial Name: NCT05954520 — N/A
Sensorineural Hearing Loss Research Study Groups: Perceptual measures
Sensorineural Hearing Loss Clinical Trial 2023: Perceptual measures Highlights & Side Effects. Trial Name: NCT05954520 — N/A
Perceptual measures 2023 Treatment Timeline for Medical Study. Trial Name: NCT05954520 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who is the ideal demographic for participating in this medical experiment?

"The criteria for inclusion in this trial necessitates that participants have a form of hearing loss caused by nerve damage and be between the ages of 18-65. At present, 50 individuals are sought to join the study."

Answered by AI

Are there available appointments for participants in this clinical investigation?

"According to the information housed on clinicaltrials.gov, this medical trial has recently reopened recruitment; its first posting was August 1st 2023 and its last update occurred August 24th of that same year."

Answered by AI

Are adults over 40 eligible to join this investigation?

"To be applicable for this trial, applicants must fall within the parameters of 18 to 65 years old. An additional 56 studies are available for those under 18 and 142 more trials exist for participants over 65."

Answered by AI

What is the maximum number of individuals who can be enlisted in this trial?

"Correct. According to medical informations posted on clinicaltrials.gov, this experiment is currently recruiting participants who can be found at one location. This trial was first advertised on August 1st 2023 and the latest update occurred 24 days later. The total number of recruited patients needs to reach 50 individuals."

Answered by AI
~28 spots leftby Feb 2025